Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer

Emaan Haque; Abdullah Esmail; Ibrahim Muhsen; Haneen Salah; Maen Abdelrahim

doi:10.3390/cancers14225615

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer

Emaan Haque, Abdullah Esmail, Ibrahim Muhsen, Haneen Salah, Maen Abdelrahim

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Gastric cancer is an enigmatic malignancy that has recently been shown to be increasing in incidence globally. There has been recent progress in emerging technologies for the diagnosis and treatment of the disease. Improvements in non-invasive diagnostic techniques with serological tests and biomarkers have led to decreased use of invasive procedures such as endoscopy. A multidisciplinary approach is used to treat gastric cancer, with recent significant advancements in systemic therapies used in combination with cytotoxic chemotherapies. New therapeutic targets have been identified and clinical trials are taking place to assess their efficacy and safety. In this review, we provide an overview of the current and emerging treatment strategies and diagnostic techniques for gastric cancer.

Original language	English (US)
Article number	5615
Journal	Cancers
Volume	14
Issue number	22
DOIs	https://doi.org/10.3390/cancers14225615
State	Published - Nov 15 2022

Keywords

biomarkers
diagnosis
gastric cancer
immunotherapy
management
monoclonal antibodies
tyrosine kinase inhibitors

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3390/cancers14225615

Cite this

@article{bdc181192a1b4c438a7ec0c8b000d3e2,

title = "Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer",

abstract = "Gastric cancer is an enigmatic malignancy that has recently been shown to be increasing in incidence globally. There has been recent progress in emerging technologies for the diagnosis and treatment of the disease. Improvements in non-invasive diagnostic techniques with serological tests and biomarkers have led to decreased use of invasive procedures such as endoscopy. A multidisciplinary approach is used to treat gastric cancer, with recent significant advancements in systemic therapies used in combination with cytotoxic chemotherapies. New therapeutic targets have been identified and clinical trials are taking place to assess their efficacy and safety. In this review, we provide an overview of the current and emerging treatment strategies and diagnostic techniques for gastric cancer.",

keywords = "biomarkers, diagnosis, gastric cancer, immunotherapy, management, monoclonal antibodies, tyrosine kinase inhibitors",

author = "Emaan Haque and Abdullah Esmail and Ibrahim Muhsen and Haneen Salah and Maen Abdelrahim",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = nov,

day = "15",

doi = "10.3390/cancers14225615",

language = "English (US)",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "22",

}

TY - JOUR

T1 - Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer

AU - Haque, Emaan

AU - Esmail, Abdullah

AU - Muhsen, Ibrahim

AU - Salah, Haneen

AU - Abdelrahim, Maen

PY - 2022/11/15

Y1 - 2022/11/15

N2 - Gastric cancer is an enigmatic malignancy that has recently been shown to be increasing in incidence globally. There has been recent progress in emerging technologies for the diagnosis and treatment of the disease. Improvements in non-invasive diagnostic techniques with serological tests and biomarkers have led to decreased use of invasive procedures such as endoscopy. A multidisciplinary approach is used to treat gastric cancer, with recent significant advancements in systemic therapies used in combination with cytotoxic chemotherapies. New therapeutic targets have been identified and clinical trials are taking place to assess their efficacy and safety. In this review, we provide an overview of the current and emerging treatment strategies and diagnostic techniques for gastric cancer.

AB - Gastric cancer is an enigmatic malignancy that has recently been shown to be increasing in incidence globally. There has been recent progress in emerging technologies for the diagnosis and treatment of the disease. Improvements in non-invasive diagnostic techniques with serological tests and biomarkers have led to decreased use of invasive procedures such as endoscopy. A multidisciplinary approach is used to treat gastric cancer, with recent significant advancements in systemic therapies used in combination with cytotoxic chemotherapies. New therapeutic targets have been identified and clinical trials are taking place to assess their efficacy and safety. In this review, we provide an overview of the current and emerging treatment strategies and diagnostic techniques for gastric cancer.

KW - biomarkers

KW - diagnosis

KW - gastric cancer

KW - immunotherapy

KW - management

KW - monoclonal antibodies

KW - tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85142535557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142535557&partnerID=8YFLogxK

U2 - 10.3390/cancers14225615

DO - 10.3390/cancers14225615

M3 - Review article

C2 - 36428707

AN - SCOPUS:85142535557

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 22

M1 - 5615

ER -

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this